Based at Georgetown University Medical Center.

Notes:.Fugh-Berman is the director of PharmedOut and serves as a paid expert on behalf of plaintiffs in litigation regarding pharmaceutical marketing practices. Based at Georgetown University Medical Center, PharmedOut a volunteer project students and health professionals, evidence-based promotion of the prescription is to educate healthcare professionals about pharmaceutical marketing practices, and access to objective information about drugs.

Family counseling improves the lives of patients and spouses Coping With Prostate Cancerfamilies dealing with prostate cancer report improved quality of life built from a structured program of support in the cancer patient management, according a new study. The results appear in the 15 December 2007 issue of Cancer, a peer-reviewed journal of the American Cancer Society. This randomized clinical trial by Dr. Laurel Northouse from the University of Michigan and co – researchers found that patients and their spouses who participated in a five – session home counseling significant improvement in areas such as symptom management, hope, uncertainty and couples ‘ ‘communication.Food and Drug Administration, the Commission and other regulatory authorities concerning each of the above product candidates, and other factors BioMarin Pharmaceutical Inc. In BioMarin’s filings the Securities and Exchange Commission, including the , described without limitation, contain which factors discussed under which heading ‘Risk Factors ‘in BioMarin is Business Review 2005 on Form 10 – C, as amended, and to factors set out in BioMarin contain reports on Form 8-K. Shareholders are urged to no inappropriately in forward-looking statements speak, to only valid a placing about date. BioMarin is undertakes no obligation, and expressly disclaims any obligation to update or revise any forward-looking statement, whether as. As a result of new information, future events or otherwise..

Primary efficacy endpoint results ofpatients receiving placebo enjoyed a 6.4 mm Hg decrease in systolic blood pressure of as compared to a fall of 4.8 mmHg in patients with BH 4 – 6R. 2007.00 was not statistically significantly.